Sampath V, Abrams EM, Adlou B, Akdis C, Akdis M, Brough HA, et al. Food allergy across the globe. J Allergy Clin Immunol. 2021;148(6):1347–64.
Shaker M, Mauger D, Fuhlbrigge AL. Value-based, cost-effective care: the role of the allergist-immunologist. J Allergy Clin Immunol Pract. 2022;11(1):132–9.
Protudjer JLP, Venter C, Groetch M, Frykas TLM, Lidington J, Kim H. The need for a food allergy educator program for allied healthcare professionals in Canada. Allergy Asthma Clin Immunol. 2022;18(1):62.
Article CAS PubMed PubMed Central Google Scholar
Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update—2014. J Allergy Clin Immunol. 2014;134(5):1016-1025.e43.
Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139(1):173-181.e8.
Article CAS PubMed Google Scholar
Klemans RJB, Otte D, Knol M, Knol EF, Meijer Y, Gmelig-Meyling FHJ, et al. The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. J Allergy Clin Immunol. 2013;131(1):157–63.
Article CAS PubMed Google Scholar
Chua GT, Greenhawt M, Shaker M, Soller L, Abrams EM, Cameron SB, et al. The case for prompt salvage infant peanut oral immunotherapy following failed primary prevention. J Allergy Clin Immunol Pract. 2022;10(10):2561–9.
Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, et al. Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med. 2016;374(15):1435–43.
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–13.
Article PubMed PubMed Central Google Scholar
Conroy E, Ponda P. How primary care providers can help prevent food allergies. Curr Opin Pediatr. 2022;34(4):430–7.
Chan ES, Dinakar C, Gonzales-Reyes E, Green TD, Gupta R, Jones D, et al. Unmet needs of children with peanut allergy. Ann Allergy Asthma Immunol. 2020;124(5):479–86.
Article CAS PubMed Google Scholar
Cafarotti A, Giovannini M, Begìn P, Brough HA, Arasi S. Management of IgE-mediated food allergy in the 21st century. Clin Exp Allergy. 2023;53(1):25–38.
Article CAS PubMed Google Scholar
Soller L, Carr S, Kapur S, Rex GA, McHenry M, Cook VE, et al. Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective. J Allergy Clin Immunol Pract. 2022;10(4):1113-1116.e1.
Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, et al. Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022;399(10322):359–71.
Article CAS PubMed Google Scholar
Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, et al. An approach to the office-based practice of food oral immunotherapy. J Allergy Clin Immunol Pract. 2021;9(5):1826-1838.e8.
Bégin P, Chan ES, Kim H, Wagner M, Cellier MS, Favron-Godbout C, et al. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2020;16(1):20.
Article PubMed PubMed Central Google Scholar
Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, et al. First real-world safety analysis of preschool peanut oral immunotherapy. J Allergy Clin Immunol Pract. 2019;7(8):2759-2767.e5.
Greenhawt M, Shaker M, Abrams EM. Peanut oral immunotherapy in very young children. The Lancet. 2022;399(10322):336–7.
Chinthrajah RS, Purington N, Andorf S, Long A, O’Laughlin KL, Lyu SC, et al. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet. 2019;394(10207):1437–49.
Article PubMed PubMed Central Google Scholar
Shaker M, Chan ES, Protudjer JLP, Soller L, Abrams EM, Greenhawt M. The cost-effectiveness of preschool peanut oral immunotherapy in the real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2876-2884.e4.
Article CAS PubMed Google Scholar
Mack DP, Soller L, Chan ES, Hanna MA, Terpstra C, Vander Leek TK, et al. A high proportion of canadian allergists offer oral immunotherapy but barriers remain. J Allergy Clin Immunol Pract. 2021;9(5):1902–8.
Article CAS PubMed Google Scholar
Lee E, Song C, Vadas P, Morgan M, Betschel S. Retrospective analysis of synchronous telemedicine use in clinical immunology and allergy (CIA): a population-based cohort study in Ontario, Canada. J Allergy Clin Immunol. 2021;147(2):AB112.
Chua GT, Chan ES, Soller L, Cook VE, Vander Leek TK, Mak R. Home-based peanut oral immunotherapy for low-risk peanut-allergic preschoolers during the COVID-19 pandemic and beyond. Front Allergy. 2021;2: 725165.
Article PubMed PubMed Central Google Scholar
Vassar M, Matthew H. The retrospective chart review: important methodological considerations. J Educ Eval Health Prof. 2013;10:12.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process: Table 1. BMJ Qual Saf. 2016;25(12):986–92.
Abrams EM, Erdle SC, Cameron SB, Soller L, Chan ES. How to incorporate oral immunotherapy into your clinical practice. Curr Allergy Asthma Rep. 2021;21(4):30.
Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol. 2010;125(3):569-574.e7.
Keet CA, Berin MC. The year in food allergy. J Allergy Clin Immunol. 2022;149(3):867–73.
Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, et al. First real-world effectiveness analysis of preschool peanut oral immunotherapy. J Allergy Clin Immunol Pract. 2021;9(3):1349-1356.e1.
Article CAS PubMed Google Scholar
Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract. 2014;2(1):91-96.e2.
Wasserman RL, Hague AR, Pence DM, Sugerman RW, Silvers SK, Rolen JG, et al. Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients. J Allergy Clin Immunol Pract. 2019;7(2):418-426.e4.
Erdle SC, Cook VE, Cameron SB, Yeung J, Kapur S, McHenry M, et al. Real-world safety analysis of preschool tree nut oral immunotherapy. J Allergy Clin Immunol Pract. 2023;11(4):1177–83.
Article CAS PubMed Google Scholar
Peters RL, Allen KJ, Dharmage SC, Koplin JJ, Dang T, Tilbrook KP, et al. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment. J Allergy Clin Immunol. 2015;135(5):1257-1266.e2.
留言 (0)